SCHEMBL1016204

SCHEMBL1016204

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(-c2cnn(COP(=O)(O)O)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.38
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
F10 P00742 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2C9 P11712 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
POLB P06746 1/20 0.35
KDR P35968 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015632 0.92 SERPINE1 (0.46) SERPINE1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL1016109 0.85 KLK7 (0.46) SERPINE1KMT2AMEN1KDM4ERXFP1
SCHEMBL1014903 0.80 SCD (0.40) SERPINE1KMT2AMEN1F10KDM4E
SCHEMBL1016339 0.79 CNR1 (0.53) SERPINE1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL1015635 0.79 CNR1 (0.51) SERPINE1KMT2AMEN1KDM4EMAPT
SCHEMBL1012911 0.78 MEN1 (0.44) SERPINE1KMT2AMEN1F10KDM4E
SCHEMBL1016964 0.78 SERPINE1 (0.51) SERPINE1KDM4EGAAPOLBKDR
SCHEMBL1015837 0.77 CNR1 (0.51) SERPINE1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL1013298 0.76 CNR1 (0.53) SERPINE1KMT2AMEN1HTTALDH1A1
SCHEMBL1015662 0.76 SERPINE1 (0.64) SERPINE1KMT2AMEN1ALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885KMT2A 3970/4885MEN1 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.